News | February 11, 2022
OPPI-QCI announce awards to celebrate excellence in manufacturing facility 2021
The awards will be conferred to the winners at the annual summit of OPPI, scheduled on March 23-24
The awards will be conferred to the winners at the annual summit of OPPI, scheduled on March 23-24
Antibiotics mixed in wastewater often get disposed of into the water bodies resulting in wider antimicrobial resistance cases
The extended collaboration will provide services relating to small molecules for both Forbion and BGV portfolio companies active in the biopharmaceutical space
SK bioscience secures long-term license to supply the Novavax vaccine for the Korean market
Up to 100 million mRNA vaccine doses could be produced in Australia each year
The Uteshiya facility, licensed by Healthium, will exclusively manufacture Healthium’s arthroscopy portfolio, including patented products in India and U.S.
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
The US $ 192.5 mn US government contract will help fund the centre of excellence to boost the domestic supply of critically needed laboratory plastics
The new facility will provide an important boost to vaccine capacity in Africa
Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers
Subscribe To Our Newsletter & Stay Updated
